Fecal microbiota transplantation is also being explored in ME/CFS research due to indications that the microbiome may significantly impact the disease, particularly its neurological symptoms [160, 161]
Writing in Acta Pharmaceutica Sinica B, researchers explained how this could seriously affect intestinal function, increasing obstruction risk: 24 "Because GLP-1RAs could cause continuous increases in the intestinal length and villus height, the small intestine may become as inelastic and fibrotic as a loose spring, leading to long-term upper intestinal obstruction ..." To date, clinical trials havent revealed such changes in the human gut, likely because its difficult to measure small intestine length
Cancer Epidemiol 57:104109
5321 for how they decided to handle what they perceived to be a problem
Faber S, Fahrenholz T, Wolle MM, Kern JC, Pamuku M, Miller L, et al